GA

Geeta Anil Sawant

Active Director Director DIN 11225729
DIN 11225729 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Geeta Anil Sawant

Data last updated:

Geeta Anil Sawant is a Director at Neocryologix Private Limited (since 2025) and Director at Neobiosurge Foundation (since 2025).

DIN 11225729
Primary Designation Director
First Appointment 02 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neocryologix Private Limited U52101PN2025PTC245137
Director18 Aug 20252025Active
Neobiosurge Foundation U94110PN2025NPL244623
Director02 Aug 20252025Active

Directorship timeline

Open interactive timeline →
Neocryologix Private Limited
Neobiosurge Foundation
Premium access

Shareholding and investment profile for Geeta Anil Sawant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Geeta Anil Sawant

Geeta Anil Sawant currently holds 2 directorships: Neocryologix Private Limited (Director, since 18 Aug 2025); Neobiosurge Foundation (Director, since 02 Aug 2025).

Geeta Anil Sawant was first appointed on 02 Aug 2025 as Director at Neobiosurge Foundation.

The current boards of Geeta Anil Sawant's companies include Anshool Prashant Sankpal (Neocryologix Private Limited), Mushtaq Abdulgafur Sayyad (Neocryologix Private Limited), Prashant Pandit Sankpal (Neobiosurge Foundation), Wajahat Mushtaq Sayyad (Neobiosurge Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available